Total Payments
$33,834
2024 Payments
$6,344
Companies
55
Transactions
787
Medicare Patients
8,061
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$33,484 (99.0%)
Other$192.09 (0.6%)
Education$157.34 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $33,484 | 777 | 99.0% |
| Education | $157.34 | 8 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101.64 | 1 | 0.3% |
| Entertainment | $90.45 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,341 | 59 | $0 (2024) |
| Novo Nordisk Inc | $3,069 | 81 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $2,541 | 34 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $2,477 | 53 | $0 (2024) |
| Amgen Inc. | $2,435 | 54 | $0 (2024) |
| Lilly USA, LLC | $1,861 | 59 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,731 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,572 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,429 | 40 | $0 (2024) |
| Organogenesis Inc. | $1,416 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,344 | 145 | Boehringer Ingelheim Pharmaceuticals, Inc. ($907.50) |
| 2023 | $3,705 | 113 | Boehringer Ingelheim Pharmaceuticals, Inc. ($594.18) |
| 2022 | $4,985 | 130 | Boehringer Ingelheim Pharmaceuticals, Inc. ($610.99) |
| 2021 | $4,965 | 129 | Amgen Inc. ($882.64) |
| 2020 | $1,732 | 45 | Novo Nordisk Inc ($173.33) |
| 2019 | $4,535 | 95 | Janssen Pharmaceuticals, Inc ($695.51) |
| 2018 | $4,181 | 72 | Novo Nordisk Inc ($984.54) |
| 2017 | $3,386 | 58 | SANOFI-AVENTIS U.S. LLC ($871.60) |
All Payment Transactions
787 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $61.18 | General |
| 12/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 12/02/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), STRAVIX PL | Food and Beverage | In-kind items and services | $158.44 | General |
| Category: Other Advanced Wound Management | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $128.53 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $121.83 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $129.64 | General |
| Category: Respiratory | ||||||
| 10/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $106.98 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $70.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,039 | 4,885 | $1.3M | $445,853 |
| 2022 | 21 | 1,928 | 4,524 | $1.1M | $382,457 |
| 2021 | 21 | 1,929 | 4,352 | $1.0M | $364,263 |
| 2020 | 28 | 2,165 | 4,750 | $966,241 | $379,248 |
Total Patients
8,061
Total Services
18,511
Medicare Billing
$1.6M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 260 | 1,601 | $400,250 | $159,187 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 337 | 1,006 | $321,700 | $100,543 | 31.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 234 | 350 | $171,500 | $50,701 | 29.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 241 | 374 | $82,280 | $35,825 | 43.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 157 | $70,650 | $28,335 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $40,400 | $16,864 | 41.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 33 | 152 | $53,020 | $15,690 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $40,590 | $13,166 | 32.4% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 18 | 93 | $29,760 | $4,550 | 15.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 277 | 501 | $5,010 | $4,201 | 83.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $9,200 | $3,952 | 43.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 39 | 39 | $6,130 | $2,930 | 47.8% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 14 | 25 | $6,500 | $2,152 | 33.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 103 | 103 | $5,051 | $1,923 | 38.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 33 | 44 | $5,720 | $1,886 | 33.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 52 | 52 | $2,600 | $1,681 | 64.6% |
| 99342 | Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 18 | 18 | $5,410 | $994.13 | 18.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 57 | 61 | $2,440 | $730.20 | 29.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $910.00 | $283.08 | 31.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 14 | 32 | $1,600 | $162.42 | 10.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 12 | 16 | $400.00 | $97.76 | 24.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 251 | 1,514 | $378,504 | $129,759 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 992 | $317,280 | $97,194 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 250 | 362 | $177,380 | $60,118 | 33.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 253 | 351 | $77,250 | $30,752 | 39.8% |
About Dr. Heyer Devarapalli, MD
Dr. Heyer Devarapalli, MD is a Internal Medicine healthcare provider based in Arlington Heights, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588704381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heyer Devarapalli, MD has received a total of $33,834 in payments from pharmaceutical and medical device companies, with $6,344 received in 2024. These payments were reported across 787 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($33,484).
As a Medicare-enrolled provider, Devarapalli has provided services to 8,061 Medicare beneficiaries, totaling 18,511 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Arlington Heights, IL
- Active Since 02/08/2007
- Last Updated 08/17/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588704381
Products in Payments
- JARDIANCE (Drug) $4,372
- XARELTO (Drug) $2,023
- ELIQUIS (Drug) $1,954
- FARXIGA (Drug) $935.56
- Ozempic (Drug) $934.67
- Repatha (Biological) $831.02
- Otezla (Drug) $791.38
- MOUNJARO (Drug) $775.45
- Puraply (Medical Supply) $771.56
- Kerendia (Drug) $743.23
- SOLIQUA (Drug) $741.43
- TOUJEO (Drug) $690.29
- Tresiba (Drug) $687.35
- Vascepa (Drug) $669.26
- EVENITY (Biological) $636.05
- VRAYLAR (Drug) $550.84
- FREESTYLE LIBRE 3 (Device) $545.08
- NEXLIZET (Drug) $534.01
- INVOKANA (Drug) $454.03
- EUCRISA (Drug) $404.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Arlington Heights
Dr. Christopher Henry, M.d, M.D
Internal Medicine — Payments: $30,489
Internal Medicine $30,489
Kevin Sohn
Internal Medicine — Payments: $22,411
Internal Medicine $22,411
Dr. Diane Flershem, M.d, M.D
Internal Medicine — Payments: $16,590
Internal Medicine $16,590
Maen Nusair, Md, MD
Internal Medicine — Payments: $14,784
Internal Medicine $14,784
Dr. Joel Robbins, Md, MD
Internal Medicine — Payments: $14,069
Internal Medicine $14,069
Dr. Hideki Shikata, M.d, M.D
Internal Medicine — Payments: $9,090
Internal Medicine $9,090